Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 14;11(7):789.
doi: 10.3390/genes11070789.

Transcriptional Profiling of Normal, Stenotic, and Regurgitant Human Aortic Valves

Affiliations

Transcriptional Profiling of Normal, Stenotic, and Regurgitant Human Aortic Valves

Christina L Greene et al. Genes (Basel). .

Abstract

The genetic mechanisms underlying aortic stenosis (AS) and aortic insufficiency (AI) disease progression remain unclear. We hypothesized that normal aortic valves and those with AS or AI all exhibit unique transcriptional profiles. Normal control (NC) aortic valves were collected from non-matched donor hearts that were otherwise acceptable for transplantation (n = 5). Valves with AS or AI (n = 5, each) were collected from patients undergoing surgical aortic valve replacement. High-throughput sequencing of total RNA revealed 6438 differentially expressed genes (DEGs) for AS vs. NC, 4994 DEGs for AI vs. NC, and 2771 DEGs for AS vs. AI. Among 21 DEGs of interest, APCDD1L, CDH6, COL10A1, HBB, IBSP, KRT14, PLEKHS1, PRSS35, and TDO2 were upregulated in both AS and AI compared to NC, whereas ALDH1L1, EPHB1, GPX3, HIF3A, and KCNT1 were downregulated in both AS and AI (p < 0.05). COL11A1, H19, HIF1A, KCNJ6, PRND, and SPP1 were upregulated only in AS, and NPY was downregulated only in AS (p < 0.05). The functional network for AS clustered around ion regulation, immune regulation, and lipid homeostasis, and that for AI clustered around ERK1/2 regulation. Overall, we report transcriptional profiling data for normal human aortic valves from non-matched donor hearts that were acceptable for transplantation and demonstrated that valves with AS and AI possess unique genetic signatures. These data create a roadmap for the development of novel therapeutics to treat AS and AI.

Keywords: RNA sequencing; aortic insufficiency; aortic stenosis; transcriptional profiling.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Differentially expressed genes in aortic valves after RNA Sequencing. (a) Venn diagram of differentially expressed genes (DEGs) in valves with aortic stenosis (AS), aortic insufficiency (AI), and normal controls (NC). (b) Volcano plots representing the distribution of gene expression in AS, AI, and NC aortic valves. The gene expression of AI vs. NC, AS vs. NC, and AS vs. AI are represented relative to statistical significance values (p < 0.05). The x-axis represents relative fold change, while the y-axis represents statistical significance. Each point represents a gene and its expression. (c) Cluster analysis of DEGs in the AS, AI, and NC groups. Increased expression is represented in red while decreased expression is represented in blue. (d) The top 30 upregulated and downregulated genes identified by RNA sequencing are identified for AS vs. NC and AI vs. NC. Gene identification and gene names are listed with the fold change and adjusted p-value (p-adj). Red represents upregulated genes relative to NC and blue represents downregulated genes relative to NC.
Figure 2
Figure 2
Confirmation of selected differentially expressed genes using quantitative polymerase chain reaction. (a) Quantitative polymerase chain reaction (qPCR) was performed for the differentially expressed genes (DEGs) with the greatest expression differences between valves with aortic stenosis (AS) or aortic insufficiency (AI) compared to the normal controls (NC), as well as for selected genes which were identified as DEGs in previous studies. Data are presented as mean ± standard error. * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001. (b) Gene expression of selected housekeeping genes ATP5F1, CYC1, and RPL32, showing no difference in expression when comparing AS, AI, and NC valves. Data are presented as mean ± standard error.
Figure 3
Figure 3
Functional network of genes involved in aortic stenosis. Each node represents a gene ontology (GO) term that has a significant number of differentially expressed genes. Edges represent known associations between GO terms. GO terms are grouped together by similarity and assigned a representative group name. Major clusters for aortic stenosis were ion regulation, immune system response, blood pressure regulation, and lipid homeostasis.
Figure 4
Figure 4
Functional network of genes involved in aortic insufficiency. Each node represents a gene ontology (GO) term that has a significant number of differentially expressed genes. Edges represent known associations between GO terms. GO terms are grouped together by similarity and assigned a representative group name. The major system for aortic insufficiency involved the ERK1 and ERK2 signaling cascade.
Figure 5
Figure 5
Protein-protein interaction model of valves with aortic stenosis. (a) Protein-protein interaction model of differentially expressed genes (DEGs) from RNA sequencing analysis of aortic stenosis (AS) versus normal control (NC) valves. DEGs found in AS versus NC alone with >3-fold change were included. The STRING database was used to generate gene relationships. STRING scores <0.7 were excluded. Edges are weighted to indicate STRING score. A list of high-impact genes was generated from these interactions. (b) High-impact genes for AS were defined as having (1) 15 or more interactions; (2) >5-fold absolute change; (3) connectivity to surrounding clusters.
Figure 6
Figure 6
Protein-protein interaction model of valves with aortic insufficiency. (a) Protein-protein interaction model of differentially expressed genes (DEGs) from RNA sequencing analysis of aortic insufficiency (AI) versus normal control (NC) valves. DEGs found in AI versus NC alone with >1.5-fold change were included. The STRING database was used to generate gene relationships. STRING scores <0.7 were excluded. Edges are weighted to indicate STRING score. A list of high-impact genes was generated from these interactions. (b) High-impact genes for AI were defined as (1) >5 interactions; (2) >2-fold absolute change; (3) connectivity to surrounding cluster.

References

    1. Benjamin E.J., Muntner P., Alonso A., Bittencourt M.S., Callaway C.W., Carson A.P., Chamberlain A.M., Chang A.R., Cheng S., das Sandeep R., et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139:e526–e528. doi: 10.1161/CIR.0000000000000659. - DOI - PubMed
    1. Baumgartner H., Falk V., Bax J.J., de Bonis M., Hamm C., Holm P.J., Iung B., Lancellotti P., Lansac E., Muñoz D.R., et al. ESC Scientific Document Group 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur. Heart J. 2017;38:2739–2791. doi: 10.1093/eurheartj/ehx391. - DOI - PubMed
    1. Yadgir S., Johnson C.O., Aboyans V., Adebayo O.M., Adedoyin R.A., Afarideh M., Alahdab F., Alashi A., Alipour V., Arabloo J., et al. Global Burden of Disease Study 2017 Nonrheumatic Valve Disease Collaborators Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990–2017. Circulation. 2020;141:1670–1680. doi: 10.1161/CIRCULATIONAHA.119.043391. - DOI - PubMed
    1. Nkomo V.T., Gardin J.M., Skelton T.N., Gottdiener J.S., Scott C.G., Enriquez-Sarano M. Burden of valvular heart diseases: A population-based study. Lancet. 2006;368:1005–1011. doi: 10.1016/S0140-6736(06)69208-8. - DOI - PubMed
    1. Carabello B.A. Introduction to aortic stenosis. Circ. Res. 2013;113:179–185. doi: 10.1161/CIRCRESAHA.113.300156. - DOI - PubMed

Publication types

MeSH terms